← Back to Dashboard

Berberine

AMP-activated protein kinase (AMPK) activator

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC
YBHILYKTIRIUTE-UHFFFAOYSA-N

Clinical Development by Virus13

Chikungunya virus
CHIKV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human betaherpesvirus 5
CMV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Influenza A virus
FLUAV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Hepacivirus C
HCV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus A
EV-A71
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus B
CVB-3
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human immunodeficiency virus 1
HIV-1
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Alphapapillomavirus 9
HPV-16
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human alphaherpesvirus 1
HSV-1
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human orthopneumovirus
RSV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Sindbis virus
SINV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Zika virus
ZIKV
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved